Dynamic42

Dynamic42 is a company headquartered in Germany. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Dynamic42 develops and produces microphysiological in vitro systems (organ-on-chip systems) for drug development and personalized medicine. These systems simulate human organs on a microchip for more precise and efficient testing of active ingredients and therapies.